Eco R1 Capital, LLC Adverum Biotechnologies, Inc. Transaction History

Eco R1 Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	BUY	$1.74 - $2.4 $1.82 Million - $2.51 Million	1,046,700 New	1,046,700 $1.84 Million
Q4 2017 Feb 14, 2018	SELL	$2.85 - $3.95 $2.17 Million - $3.01 Million	-762,947 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$2.45 - $3.65 $1.87 Million - $2.78 Million	762,947	762,947 $2.79 Million

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.